Nutraceutical & Health Supplement Compliance

A foundational point about nutraceuticals in India is that they are regulated as a special category of food under the FSSAI, not as drugs under the medicines framework. This shapes everything: the licensing, the labelling, the claims, and above all the boundary the sector must respect. A supplement may support health, but it cannot cross into claiming to treat, cure or prevent disease — that is the territory of medicines, and a nutraceutical that makes disease claims risks being treated as an unlicensed drug, a far more serious problem than a food-labelling issue.

Understanding and respecting this food-not-medicine boundary is central to compliant nutraceutical marketing, and it is where enthusiastic brands most often stray. The appeal of a supplement is its health benefit, and the temptation to claim more than the food framework allows is strong, but crossing the line invites exactly the regulatory trouble the category is designed to avoid. We help supplement businesses position their products correctly within the food framework, so they convey genuine benefit without straying into medicinal claims that would upend their regulatory status.

• Nutraceuticals are regulated as a special category of food, not as drugs.
• They may support health but cannot claim to treat or cure disease.
• Crossing into medicinal claims risks being treated as an unlicensed drug.

For nutraceuticals, compliance begins and often ends with the formulation. The regulations set out which ingredients — vitamins, minerals, botanicals, amino acids, probiotics and others — may be used in supplements, and in what quantities, and a product is only compliant if its composition sits within these permissions. This is a detailed, technical assessment: each ingredient has to be checked against the permitted lists, and each quantity against the allowed limits, before a product can confidently go to market.

We vet formulations rigorously against the regulations, ingredient by ingredient and level by level, so any problem is identified before the product is committed rather than after it is refused or challenged. Where a formulation has an issue — a non-permitted ingredient, an over-limit dose — knowing it early lets a brand reformulate, seek approval, or reconsider, all far cheaper than discovering it late. This formulation vetting is the single most valuable thing we do for a nutraceutical, because it is where the product’s compliance is truly determined.

A particular focus of nutraceutical formulation is quantity, and specifically the limits — frequently anchored to Recommended Daily Allowance levels — on how much of a nutrient a supplement may contain. The regulations do not simply permit ingredients; they cap them, often at or around RDA-based thresholds, on the sound principle that supplements should supplement rather than deliver pharmacological doses. A brand that assumes more is better, and packs in a nutrient well above the permitted level, has a non-compliant product regardless of how it is marketed.

This trips up importers especially, because supplement formulations designed for markets with different or higher limits often exceed the Indian ceilings, so a product that is perfectly legal abroad can be non-compliant here on dosage alone. We check formulations specifically against the Indian limits, flag where a product exceeds them, and advise on reformulation to bring it within the ceilings. Getting the quantities right — not just the ingredients — is essential, and it is a common and costly oversight for brands new to the Indian nutraceutical rules.

• Ingredients are capped, often around RDA-based limits.
• Supplements should supplement, not deliver drug-like doses.
• Imported formulations often exceed Indian limits on dosage.

When a nutraceutical uses an ingredient, or is of a kind, not covered by the specified permitted lists, it cannot simply be sold on the manufacturer’s say-so; it requires a non-specified food approval from the FSSAI. This is a distinct and more demanding process, in which the safety of the novel ingredient or product has to be established to the satisfaction of the FSSAI’s scientific evaluation before market entry. It exists so that genuinely new ingredients enter the food supply only after their safety is assessed, and it is the correct route for innovation that goes beyond the existing lists.

We identify when a product genuinely needs non-specified food approval — a judgement that itself requires familiarity with what the specified lists cover — and guide the application, including assembling the safety dossier the scientific evaluation requires. Misjudging this is a serious error: selling a product that needed approval without it is a real contravention, while unnecessarily pursuing approval for a permitted ingredient wastes time and money. We get this judgement right, so novel products take the proper route and permitted ones are not needlessly delayed.

Beyond formulation, nutraceuticals carry the standard food-compliance obligations shaped to their category. The operation needs the appropriate FSSAI licence — the level depending on scale and activity — and the product needs labelling that meets the requirements for supplements, including the specific declarations, the category identification, and the mandatory warnings and advisories the rules require for this class of product. These are detailed and specific to the supplement category, and generic food labelling does not automatically satisfy them.

Health claims deserve particular care. Any claim a supplement makes about its benefits must be substantiated and framed within what the regulations permit, and the FSSAI scrutinises claims in this category closely because of the temptation to overstate. We help ensure the FSSAI licence is right for the operation, the labelling meets the supplement-specific requirements, and the health claims are both supported and lawfully framed — so the product is compliant not just in what it contains but in how it is licensed, labelled and marketed.

The nutraceutical sector is full of new entrants and importers bringing international supplement brands to India, and this group faces the compliance challenges most acutely. An imported supplement typically arrives with a formulation designed for another market, labelling built for other rules, and claims framed under a different regime — and each of these usually needs work to meet the Indian requirements. The excitement of entering a fast-growing market can obscure how much regulatory adaptation a foreign supplement actually needs.

We are particularly attuned to this, guiding importers and new brands through the whole adaptation: vetting the formulation against Indian limits, pursuing non-specified food approval where the product needs it, redesigning labelling for the Indian rules, and reframing claims within the food framework. For a business betting on India’s appetite for supplements, this thorough compliance groundwork is what turns an ambitious market entry into a durable one, rather than a launch that stumbles into regulatory trouble because the product was not properly adapted.